Centro Andaluz de Biología Molecular y Medicina Regenerativa, Consejo Superior de Investigaciones Científicas, Sevilla, Spain.
Apoptosis. 2012 Apr;17(4):349-63. doi: 10.1007/s10495-011-0673-2.
Despite recent evidences suggesting that agents inducing endoplasmic reticulum (ER) stress could be exploited as potential antitumor drugs in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), the mechanisms of this anticancer action are not fully understood. Moreover, the effects of ER stress and TRAIL in nontransformed cells remain to be investigated. In this study we report that ER stress-inducing agents sensitizes both transformed and nontransformed cells to TRAIL-induced apoptosis. In addition, glucose-regulated protein of 78 kDa (GRP78) knockdown by RNA interference induces ER stress and facilitates apoptosis by TRAIL. We demonstrate that TRAIL death-inducing signaling complex (DISC) formation and early signaling are enhanced in ER stressed cells. ER stress alters the cellular levels of different apoptosis-related proteins including a decline in the levels of FLIP and Mcl-1 and the up-regulation of TRAIL-R2. Up-regulation of TRAIL-R2 following ER stress is dependent on the expression of PKR-like ER kinase (PERK) and independent of CAAT/enhancer binding protein homologous protein (CHOP) and Ire1α. Silencing of TRAIL-R2 expression by siRNA blocks the ER stress-mediated sensitization to TRAIL-induced apoptosis. Furthermore, simultaneous silencing of cFLIP and Mcl-1 expression by RNA interference results in a marked sensitization to TRAIL-induced apoptosis. Finally, in FLIP-overexpressing cells ER stress-induced sensitization to TRAIL-activated apoptosis is markedly reduced. In summary, our data reveal a pleiotropic mechanism involving both apoptotic and anti-apoptotic proteins for the sensitizing effect of ER stress on the regulation of TRAIL receptor-mediated apoptosis in both transformed and nontransformed cells.
尽管最近有证据表明,内质网(ER)应激诱导剂与肿瘤坏死因子相关凋亡诱导配体(TRAIL)联合使用可能被开发为潜在的抗肿瘤药物,但这种抗癌作用的机制尚不完全清楚。此外,内质网应激和 TRAIL 在非转化细胞中的作用仍有待研究。在这项研究中,我们报告内质网应激诱导剂可增强转化和非转化细胞对 TRAIL 诱导的细胞凋亡的敏感性。此外,通过 RNA 干扰敲低葡萄糖调节蛋白 78kDa(GRP78)可诱导内质网应激,并通过 TRAIL 促进细胞凋亡。我们证明内质网应激细胞中 TRAIL 死亡诱导信号复合物(DISC)的形成和早期信号增强。内质网应激改变了不同凋亡相关蛋白的细胞水平,包括 FLIP 和 Mcl-1 水平下降以及 TRAIL-R2 的上调。内质网应激后 TRAIL-R2 的上调依赖于 PKR 样内质网激酶(PERK)的表达,而不依赖于 CAAT/增强子结合蛋白同源蛋白(CHOP)和 Ire1α。通过 siRNA 沉默 TRAIL-R2 表达可阻断内质网应激介导的对 TRAIL 诱导的细胞凋亡的敏感性。此外,通过 RNA 干扰同时沉默 cFLIP 和 Mcl-1 的表达可导致对 TRAIL 诱导的细胞凋亡的显著敏感性增加。最后,在 FLIP 过表达细胞中,内质网应激诱导的对 TRAIL 激活的细胞凋亡的敏感性明显降低。总之,我们的数据揭示了一种涉及凋亡和抗凋亡蛋白的多效性机制,内质网应激通过该机制调节转化和非转化细胞中 TRAIL 受体介导的细胞凋亡。